Top compounds associated with response to C22orf31


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA Bicalutamide FIMM pan-cancer AAC 0.38 0.03
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.074 0.03
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.07 0.03
mRNA itraconazole CTRPv2 pan-cancer AAC 0.084 0.03
mRNA PHA-793887 CTRPv2 pan-cancer AAC 0.068 0.03
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.07 0.03
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.093 0.03
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.078 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.03
Download CSV